Toronto Accelerator Fosters Made-In-Canada Approach To Cell Therapy

Originally published by Canadian Manufacturing

The global pandemic has put the spotlight on health sciences and their importance to the economy.

This is according to Michael May, president and CEO of CCRM, a Toronto-based accelerator that develops and commercializes cell and gene therapies and regenerative medicine technologies.

May said, “COVID-19 has put a microscope on healthcare as a driver of not only the economy but something that can impact our lives regardless of what we’re doing.”

He continued, “It has put a positive lens on healthcare and life sciences and is helping us articulate that this is an important thing to invest in.”

However, May notes that Canada imports most of its healthcare expertise, something that CCRM is aiming to change.